HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes.

Abstract
Epithelial-mesenchymal transition (EMT) is a crucial event in wound healing, tissue repair, and cancer progression in adult tissues. Transforming growth factor (TGF)-β induces EMT in mouse epithelial cells. During prolonged treatment, TGF-β successively induces myofibroblastic differentiation with increased expression of myofibroblast marker proteins, including smooth muscle α actin and calponin. We recently showed that fibroblast growth factor-2 prevented myofibroblastic differentiation induced by TGF-β, and transdifferentiated the cells to those with much more aggressive characteristics (enhanced EMT). To identify the molecular markers specifically expressed in cells undergoing enhanced EMT induced by the combination of TGF-β and fibroblast growth factor-2, we carried out a microarray-based analysis and found that integrin α3 (ITGA3) and Ret were upregulated. Intriguingly, ITGA3 was also overexpressed in breast cancer cells with aggressive phenotypes and its expression was correlated with that of δEF-1, a key regulator of EMT. Moreover, the expression of both genes was downregulated by U0126, a MEK 1/2 inhibitor. Therefore, ITGA3 is a potential marker protein for cells undergoing enhanced EMT and for cancer cells with aggressive phenotypes, which is positively regulated by δEF-1 and the MEK-ERK pathway.
AuthorsTakuya Shirakihara, Tomonori Kawasaki, Akihiko Fukagawa, Kentaro Semba, Ryuichi Sakai, Kohei Miyazono, Keiji Miyazawa, Masao Saitoh
JournalCancer science (Cancer Sci) Vol. 104 Issue 9 Pg. 1189-97 (Sep 2013) ISSN: 1349-7006 [Electronic] England
PMID23786209 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 Japanese Cancer Association.
Chemical References
  • Biomarkers, Tumor
  • Integrin alpha3
  • Transcription Factors
  • Transforming Growth Factor beta1
  • Fibroblast Growth Factor 2
  • Proto-Oncogene Proteins c-ret
Topics
  • Animals
  • Biomarkers, Tumor (genetics, metabolism)
  • Cell Differentiation (genetics)
  • Cell Line, Tumor
  • Cells, Cultured
  • Down-Regulation
  • Epithelial-Mesenchymal Transition (drug effects)
  • Fibroblast Growth Factor 2 (genetics, metabolism, pharmacology)
  • Gene Expression Profiling (methods)
  • Humans
  • Integrin alpha3 (genetics, metabolism)
  • MAP Kinase Signaling System
  • Mice
  • Myofibroblasts (metabolism)
  • Phenotype
  • Proto-Oncogene Proteins c-ret (genetics, metabolism)
  • Transcription Factors (genetics, metabolism)
  • Transforming Growth Factor beta1 (genetics, metabolism, pharmacology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: